Retatrutide — Triple Agonist Research Peptide (GLP-1 / GIP / Glucagon)

✦ Janoshik Verified · ≥99% Purity · Ships from Ontario · Research Use Only

One of the most discussed next-generation metabolic research compounds in the scientific literature. Retatrutide is a triple receptor agonist — targeting the GLP-1, GIP, and glucagon receptors simultaneously — and a frequent focus of academic and preclinical study in the obesity and cardiometabolic research space. Supplied by Clair Lab with a publicly accessible Janoshik Certificate of Analysis linked on this page.

Specifications

• Format: Lyophilized powder, sterile vial
• Purity: ≥99% confirmed by HPLC + Mass Spectrometry
• Testing: Janoshik Analytical (independent third-party)
• Storage: −20°C, away from light and moisture
• Reconstitution: Bacteriostatic water recommended
• Ships from: Ontario, Canada — 1–2 business days to most of Canada

🔬 Third-Party COA: View Janoshik Certificate of Analysis →

COA reflects product-level testing conducted by Janoshik Analytical, consistent with industry standard for research peptide suppliers.

⚠️ For Research Use Only. All Clair Lab compounds are sold strictly for in vitro laboratory research purposes. Not for human or animal consumption. Not approved by Health Canada for therapeutic use. By purchasing, you confirm this product will be used for legitimate research purposes only.

Clair Lab · Independently tested research compounds · Shipped from Ontario, Canada